Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Margel

Showing results (81-90 of 101) with videos related to

Pageof 11
Sort By:
Urologic Oncology|February 16, 2025
Impact of baseline PD-L1 status in BCG naive nonmuscle invasive bladder cancer on outcomes and changes after BCG exposureThomas Gerald, Solomon L Woldu, Daniel Halstuch, et al.
The Journal of Urology|July 14, 2021
Reply by AuthorsKarin Lifshitz, Yaara Ber, Chen Shenhar, et al.
The Journal of Urology|May 25, 2021
Cardiovascular Proteomics: A Post Hoc Analysis from a Phase II Randomized Clinical Trial Comparing GnRH Antagonist vs GnRH Agonist among Men with Advanced Prostate CancerKarin Lifshitz, Yaara Ber, Chen Shenhar, et al.
Urologic Oncology|July 17, 2014
Thromboembolic events in patients with urothelial carcinoma undergoing neoadjuvant chemotherapy and radical cystectomyPiotr Zareba, Laurel Patterson, Rishikesh Pandya, et al.
Harefuah|June 30, 2017
[THE MULTIDISCIPLINARY MUSCLE INVASIVE BLADDER CANCER CLINIC AT THE RABIN MEDICAL CENTER]Sharon Noroheimer, Rachel Ozalvo, Amir Abramovich, et al.
Carcinogenesis|May 28, 2020
3,3-Diindolylmethane (DIM): a nutritional intervention and its impact on breast density in healthy BRCA carriers. A prospective clinical trialRinat Yerushalmi, Sharon Bargil, Yaara Ber, et al.
European Urology Oncology|October 10, 2022
Neoadjuvant <sup>177</sup>Lu-PSMA-I&T Radionuclide Treatment in Patients with High-risk Prostate Cancer Before Radical Prostatectomy: A Single-arm Phase 1 TrialShay Golan, Michael Frumer, Yarden Zohar, et al.
The Journal of Urology|June 13, 2019
Cardiovascular Morbidity in a Randomized Trial Comparing GnRH Agonist and GnRH Antagonist among Patients with Advanced Prostate Cancer and Preexisting Cardiovascular DiseaseDavid Margel, Avivit Peer, Yaara Ber, et al.
Oncotarget|April 18, 2018
Premature ovarian aging in <i>BRCA</i> carriers: a prototype of systemic precocious aging?Irit Ben-Aharon, Mattan Levi, David Margel, et al.
The Journal of Urology|September 6, 2019
Reply By AuthorsDavid Margel, Avivit Peer, Yaara Ber, et al.
Pageof 11

Showing results (81-90 of 101) with videos related to

Sort By:
Pageof 11
Urologic Oncology|February 16, 2025
Impact of baseline PD-L1 status in BCG naive nonmuscle invasive bladder cancer on outcomes and changes after BCG exposureThomas Gerald, Solomon L Woldu, Daniel Halstuch, et al.
The Journal of Urology|July 14, 2021
Reply by AuthorsKarin Lifshitz, Yaara Ber, Chen Shenhar, et al.
The Journal of Urology|May 25, 2021
Cardiovascular Proteomics: A Post Hoc Analysis from a Phase II Randomized Clinical Trial Comparing GnRH Antagonist vs GnRH Agonist among Men with Advanced Prostate CancerKarin Lifshitz, Yaara Ber, Chen Shenhar, et al.
Urologic Oncology|July 17, 2014
Thromboembolic events in patients with urothelial carcinoma undergoing neoadjuvant chemotherapy and radical cystectomyPiotr Zareba, Laurel Patterson, Rishikesh Pandya, et al.
Harefuah|June 30, 2017
[THE MULTIDISCIPLINARY MUSCLE INVASIVE BLADDER CANCER CLINIC AT THE RABIN MEDICAL CENTER]Sharon Noroheimer, Rachel Ozalvo, Amir Abramovich, et al.
Carcinogenesis|May 28, 2020
3,3-Diindolylmethane (DIM): a nutritional intervention and its impact on breast density in healthy BRCA carriers. A prospective clinical trialRinat Yerushalmi, Sharon Bargil, Yaara Ber, et al.
European Urology Oncology|October 10, 2022
Neoadjuvant <sup>177</sup>Lu-PSMA-I&T Radionuclide Treatment in Patients with High-risk Prostate Cancer Before Radical Prostatectomy: A Single-arm Phase 1 TrialShay Golan, Michael Frumer, Yarden Zohar, et al.
The Journal of Urology|June 13, 2019
Cardiovascular Morbidity in a Randomized Trial Comparing GnRH Agonist and GnRH Antagonist among Patients with Advanced Prostate Cancer and Preexisting Cardiovascular DiseaseDavid Margel, Avivit Peer, Yaara Ber, et al.
Oncotarget|April 18, 2018
Premature ovarian aging in <i>BRCA</i> carriers: a prototype of systemic precocious aging?Irit Ben-Aharon, Mattan Levi, David Margel, et al.
The Journal of Urology|September 6, 2019
Reply By AuthorsDavid Margel, Avivit Peer, Yaara Ber, et al.
Pageof 11